Immune Design (IMDZ) Tops Q1 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- S&P Global explores potential separation of Capital IQ business
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
Cowen Starts Immune Design (IMDZ) at Outperform
May 15, 2015 7:04 AM EDTCowen initiated coverage on Immune Design (NASDAQ: IMDZ) with an Outperform rating.
For an analyst ratings summary and ratings history on Immune Design click here. For more ratings news on Immune Design click here.
Shares of Immune Design closed at $21.29 yesterday.
... More


